Register
Login:
Share:
Email Facebook Twitter

#AST: Board changes and new strategy for Ascent as Hutchinson looks at new projects Watch Here

#AST: Board changes and new strategy for Ascent as Hutchinson looks at new projects
EXCLUSIVE: Petro Matad announce fully funded 4 well Mongolia campaign




Share Price Information for Glaxosmithkline (GSK)


Share Price: 1,485.20Bid: 1,484.80Ask: 1,485.20Change: -23.40 (-1.55%)Faller - Glaxosmithkline
Spread: 0.40Spread as %: 0.03%Open: 1,506.40High: 1,506.40Low: 1,478.40Yesterday’s Close: 1,508.60

Glaxosmithkline Plc Ord 25P

Glaxosmithkline is listed in the FTSE 100, FTSE All-Share, FTSE 350, FTSE 350 High Yield
Glaxosmithkline is part of the Medicine and Biotech Research sector

Glaxosmithkline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 96,500 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries.





Share Price SpacerPrice
1485.20
Share Price SpacerBid
1484.80
Share Price SpacerAsk
1485.20
Share Price SpacerChange
-1.55%-23.40
Share Price SpacerVolume
3,084,515
Share Price SpacerOpen
1,506.40
Share Price SpacerHigh
1,506.40
Share Price SpacerLow
1,478.40
Share Price SpacerClose
1,508.60
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 4,919.00m £73,056.99m 1,500

52 Week High 1,648.80 52 Week High Date 3-DEC-2018
52 Week Low 1,236.40 52 Week Low Date 6-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
8,990 1,435,170 1,560,582 47.299 31.40 80.00 5.39


London South East Users info for Glaxosmithkline


Users who watch GSK also watch: Lloyds, BP, Vodafone, Tesco, Barclays, RBS, HSBC, National Grid, BT, Aviva

Users who hold GSK also hold: Vodafone, BP, Lloyds, National Grid, Royal Dutch Shell B, Tesco, HSBC, Aviva, Centrica, BT


Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

16-Jan-19
15:03:46
1,485.60
361
Sell* 
1,485.40
1,485.80
5,363
Trade Type:
Automatic execution

16-Jan-19
15:03:46
1,485.60
306
Buy* 
1,485.40
1,485.60
4,546
Trade Type:
Automatic execution

16-Jan-19
15:03:46
1,485.60
567
Buy* 
1,485.40
1,485.60
8,423
Trade Type:
Automatic execution




View more Glaxosmithkline trades >>

Directors Deals for Glaxosmithkline (GSK)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-Jan-19Buy Dividends
Trade Notifier Information for GlaxoSmithKline
David Redfern held the position of Chief Strategy Officer at GlaxoSmithKline at the time of this trade.
 David Redfern
1540GBX24140528
11-Jan-19Buy Dividends
Trade Notifier Information for GlaxoSmithKline
Victoria Whyte held the position of Company Secretary at GlaxoSmithKline at the time of this trade.
 Victoria Whyte
1540GBX2030008
11-Jan-19Buy Dividends
Trade Notifier Information for GlaxoSmithKline
Emma Walmsley held the position of CEO at GlaxoSmithKline at the time of this trade.
 Emma Walmsley
1528.75GBX1,535209333
View more Glaxosmithkline directors dealings >>


driftking27
Posts: 1,427
Opinion:Hold
Price:1,521.20
GSK drug pipeline presentation
Fri 12:19
Yes the presentation did go ahead this week. I saw Emma on Bloomberg tv talking about her change in business model. The analysts seem to like her talk.

I still harp on about this, if GSK lowered the dividend to maybe 4.5% it help their cash flow.

I currently hold GSK & NVS and am looking to buy PFE this year..
ge0rge123
Posts: 665
Opinion:No Opinion
Price:1,537.00
RE: Iknowverylittke
9 Jan '19
Must not..typo
ge0rge123
Posts: 665
Opinion:No Opinion
Price:1,537.00
Iknowverylittke
9 Jan '19
Not sure buddy..but if she did it mustake not have been mind blowing..
iknowverylittle
Posts: 387
Opinion:No Opinion
Price:1,534.00
RE: Emma's presentation
9 Jan '19
Bit of a rise today, anyone know if the presentation happened?
ge0rge123
Posts: 665
Opinion:Buy
Price:1,518.60
Emma's presentation
6 Jan '19
To investors on Tuesday at JP Morgans bash could be interesting
View more share chat for Glaxosmithkline (GSK) >>




Glaxosmithkline Plc Ord 25P home pageWebsite: Glaxosmithkline Plc Ord 25P
Website Description: GlaxoSmithKline has a share of around 5% of the world's pharmaceutical market, aiming to tackle 3 of the 'priority' diseases identified by the World Health Organisation. The company employs around 99,300 people in over 100 countries. In 2010 they delivered 1.4 billion vaccine doses to 179 countries. As of August 2016 it had a market capitalisation of £81 billion the fourth largest on the London Stock Exchange



Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.